As a leading manufacturer in peptide synthesis, we specialize in producing high quality xcel semaglutide intermediates for research applications. Our product Arg34GLP-1(9-37) (CAS 1169630-82-3) is manufactured under strict quality control to ensure purity and consistency.
The xcel semaglutide intermediates we produce are essential building blocks in pharmaceutical research, particularly in diabetes and obesity treatment development. Our advanced synthesis technology allows us to maintain exceptional purity levels while offering competitive pricing for bulk orders.
With our expertise in peptide modification including acetylation, amination, and biotin labeling, we can provide customized solutions to meet specific research requirements. Our team of experienced scientists ensures every batch meets rigorous quality standards.
For research institutions and pharmaceutical companies, we offer flexible ordering options from small trial quantities to large-scale production. All our xcel semaglutide products are strictly for research use only and not intended for human consumption.